Development asset linked to Zhejiang Provincial People's in public FDA and regional records. Molecular target: Programmed cell death protein 1.
- Target
- Programmed cell death protein 1
- Mechanism
- Programmed cell death protein 1 inhibitor
pharma · Pancreatic Cancer
Zhejiang Provincial People's
Zhejiang Provincial People's Hospital
Zhejiang Provincial People's drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Zhejiang Provincial People's pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Zhejiang Provincial People's drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.